Evidence mapPaperPMID 42352239Full record

ReviewBiomolecules2026

NMDA Receptor Mediated Mechanisms in the Post-Stroke Brain: From Physiology to Pathology.

Han Gong, Xiang-Zheng Wang, Dan Liu, Wei-Jin Liu, Xiao-Xia Du, Jia-Sheng Rao

Abstract readReview
In one paragraph

Review in Biomolecules, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Han GongBeijing Key Laboratory for Biomaterials and Neural Regeneration, National Medical Innovation Platform for Industry-Education Integration in Advanced Medical Devices (Interdiscipline of Medicine and Engineering), School of Biological Science and Medical Engineering, Beihang University, Beijing 100191, China.
Xiang-Zheng WangSchool of Rehabilitation Medicine, Wenzhou Medical University, Wenzhou 325000, China.
Dan LiuSchool of Rehabilitation, Capital Medical University, Beijing 100086, China.
Wei-Jin LiuChina Rehabilitation Science Institute, Beijing 100086, China.ORCID 0009-0006-9167-890X
Xiao-Xia DuChina Rehabilitation Research Center, Beijing 100086, China.ORCID 0009-0002-8686-2236
Jia-Sheng RaoBeijing Key Laboratory for Biomaterials and Neural Regeneration, National Medical Innovation Platform for Industry-Education Integration in Advanced Medical Devices (Interdiscipline of Medicine and Engineering), School of Biological Science and Medical Engineering, Beihang University, Beijing 100191, China.

Funding

China Rehabilitation Science Institute CRSI2025ZH-3
6 · The paper itself

Abstract

N-methyl-D-aspartate receptors (NMDARs) play a context-dependent role in ischemic stroke (IS), contributing to acute excitotoxic injury while also supporting subsequent neuroplasticity. This functional divergence has constrained the therapeutic efficacy of non-selective NMDAR antagonists. During the acute phase, neuronal injury is associated with the redistribution of NMDARs toward extrasynaptic sites and the activation of aberrant non-ionotropic signaling pathways. As the disease progresses, NMDAR-dependent signaling becomes increasingly involved in activity-dependent plasticity, including motor engram consolidation, dendritic remodeling, and large-scale network reorganization. Post-stroke cognitive impairment and depression are increasingly recognized as potential consequences of sustained NMDAR dysregulation, involving interactions with immune signaling and metabolic processes. These observations support a shift toward activity-dependent modulation of NMDAR function, in which neurotoxic signaling is selectively dissociated from physiological receptor activity. Emerging strategies aimed at subunit-specific modulation and disruption of pathological receptor complexes provide a basis for more targeted intervention. Preservation of physiological excitation-inhibition balance may therefore represent a key requirement for optimizing functional recovery after stroke.

Indexed as

BrainReceptors, N-Methyl-D-AspartateStrokeAnimalsHumansNeuronal PlasticitySignal TransductionReceptors, N-Methyl-D-Aspartateexcitation-inhibition balanceexcitotoxicityischemic strokeneuroplasticityneuroprotectionNMDA receptorpathophysiology

Identifiers

PMID42352239
PMCPMC13296956

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.